Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Single-use Bioprocessing Equipment, Simple and Peripheral Devices), By Applications (Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, Others), By End-Users (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), R&D Companies and Research Institutes), By Method (Filtration, Storage and Transport, Cell Culture, Mixing, Purification) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:

Market Segmentation

  1. Single-use Bioprocessing Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Single-use Bioprocessing Equipment
    2. Simple and Peripheral Devices
  2. Single-use Bioprocessing Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies (mABs)
    2. Vaccines
    3. Cell Therapies
    4. Others
  3. Single-use Bioprocessing Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical Manufacturers
    2. Contract Manufacturing Organizations (CMOs)
    3. R&D Companies and Research Institutes
  4. Single-use Bioprocessing Market, By Method 2022-2034 (USD MILLION/ Units)
    1. Filtration
    2. Storage and Transport
    3. Cell Culture
    4. Mixing
    5. Purification
  5. Regional Single-use Bioprocessing Market
    1. North America
      1. North America Single-use Bioprocessing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
      2. North America Single-use Bioprocessing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mABs)
        2. Vaccines
        3. Cell Therapies
        4. Others
      3. North America Single-use Bioprocessing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Manufacturers
        2. Contract Manufacturing Organizations (CMOs)
        3. R&D Companies and Research Institutes
      4. North America Single-use Bioprocessing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Filtration
        2. Storage and Transport
        3. Cell Culture
        4. Mixing
        5. Purification
      5. U.S.
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      6. Canada
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
    2. Europe
      1. Europe Single-use Bioprocessing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
      2. Europe Single-use Bioprocessing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mABs)
        2. Vaccines
        3. Cell Therapies
        4. Others
      3. Europe Single-use Bioprocessing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Manufacturers
        2. Contract Manufacturing Organizations (CMOs)
        3. R&D Companies and Research Institutes
      4. Europe Single-use Bioprocessing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Filtration
        2. Storage and Transport
        3. Cell Culture
        4. Mixing
        5. Purification
      5. U.K.
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      6. Germany
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      7. France
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      8. Spain
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      9. Italy
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      10. Russia
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      11. Nordic
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      12. Benelux
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      13. Rest of Europe
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
    3. APAC
      1. APAC Single-use Bioprocessing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
      2. APAC Single-use Bioprocessing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mABs)
        2. Vaccines
        3. Cell Therapies
        4. Others
      3. APAC Single-use Bioprocessing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Manufacturers
        2. Contract Manufacturing Organizations (CMOs)
        3. R&D Companies and Research Institutes
      4. APAC Single-use Bioprocessing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Filtration
        2. Storage and Transport
        3. Cell Culture
        4. Mixing
        5. Purification
      5. China
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      6. Korea
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      7. Japan
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      8. India
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      9. Australia
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      10. Singapore
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      11. Taiwan
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      12. South East Asia
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      13. Rest of Asia-Pacific
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
    4. Middle East and Africa
      1. Middle East and Africa Single-use Bioprocessing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
      2. Middle East and Africa Single-use Bioprocessing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mABs)
        2. Vaccines
        3. Cell Therapies
        4. Others
      3. Middle East and Africa Single-use Bioprocessing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Manufacturers
        2. Contract Manufacturing Organizations (CMOs)
        3. R&D Companies and Research Institutes
      4. Middle East and Africa Single-use Bioprocessing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Filtration
        2. Storage and Transport
        3. Cell Culture
        4. Mixing
        5. Purification
      5. UAE
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      6. Turkey
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      7. Saudi Arabia
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      8. South Africa
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      9. Egypt
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      10. Nigeria
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      11. Rest of MEA
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
    5. LATAM
      1. LATAM Single-use Bioprocessing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
      2. LATAM Single-use Bioprocessing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mABs)
        2. Vaccines
        3. Cell Therapies
        4. Others
      3. LATAM Single-use Bioprocessing Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Manufacturers
        2. Contract Manufacturing Organizations (CMOs)
        3. R&D Companies and Research Institutes
      4. LATAM Single-use Bioprocessing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Filtration
        2. Storage and Transport
        3. Cell Culture
        4. Mixing
        5. Purification
      5. Brazil
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      6. Mexico
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      7. Argentina
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      8. Chile
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      9. Colombia
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification
      10. Rest of LATAM
        1. Single-use Bioprocessing Equipment
        2. Simple and Peripheral Devices
        3. Monoclonal Antibodies (mABs)
        4. Vaccines
        5. Cell Therapies
        6. Others
        7. Biopharmaceutical Manufacturers
        8. Contract Manufacturing Organizations (CMOs)
        9. R&D Companies and Research Institutes
        10. Filtration
        11. Storage and Transport
        12. Cell Culture
        13. Mixing
        14. Purification

We are featured on: